BiomX Inc.’s Bacteriophage Therapy Offers New Hope Against Antibiotic-Resistant Infections
The battle against antibiotic-resistant infections, a dire global health crisis, may have found a new ally in BiomX Inc.’s bacteriophage therapy. Recent Phase 2 clinical trial results have shown significant promise in treating diabetic foot osteomyelitis and cystic fibrosis, conditions notoriously difficult to manage with traditional antibiotics. This development is particularly timely, given the World […]